Login

Home / Search

Search

By Author

Published After

Published Before

Clear Filters

17 Search Results

Can the Early Warning Score (ANDC) Predict Tocilizumab Efficacy in Patients with COVID-19 Cytokine Storm?

Özlem Kılıç, Duygu Tecer, Mehmet Nur Kaya, Muhammet Çınar, Sedat Yılmaz

Full Text

DOI

Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study

Abhishek Kumar, D. S. Bhakuni, Sivasami Kartik, Arun Hegde, K. Shanmuganandan, Kavita Singh, Vivek Vasdev, Arjun MN

Full Text

DOI

Severe Infections in Patients Treated with Tocilizumab for Systemic Diseases Other Than Rheumatoid Arthritis: A Retrospective Multicenter Observational Study

Florent Broca, Odile Souchaud-Debouverie, Evelyne Liuu, Pascal Roblot, Mickaël Martin

Full Text

DOI

Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF

Sedat Yılmaz, Emre Tekgöz, Muhammet Çınar

Full Text

DOI

In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls

Helene Broch Tenstad, Pernille Just Vinholt, Christian Nielsen, Hanne Lindegaard, Søren Andreas Just

Full Text

DOI

Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab

Yusuf Karabulut

Full Text

DOI

What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?

Cansu Akleylek, Seray Gizem Gür, Ibrahim Halil Sever, Safiye Koçulu Demir, Esin Cevik, Egemen Eken, Zafer Gökkaya, Yonca Çağatay, Neslihan Yılmaz

Full Text

DOI

Anti IL-6 Treatment for Calcium Pyrophosphate Disease Report of 4 Cases and a Short Literature Review

Amir Bieber, Angelo Tropea, Shay Brikman, Antonino Palumbo, Fabiola Atzeni

Full Text

DOI

Successful treatment of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with tocilizumab: a case report

Nessrine Akasbi, Muhammad S Soyfoo

Full Text

DOI

Long-Term Effect and Safety of Tocilizumab on Severe Adult-Onset Still’s Disease Accompanied by Thrombotic Thrombocytopenic Purpura

Tatsuya Suwabe, Masayuki Yamanouchi, Yoshifumi Ubara, Naoki Sawa

Full Text

DOI

Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy

Osvaldo Luis Cerda, María de los Angeles Correa, Amelia Granel, Ana Ines Marcos, Claudia Giraldo, Oscar Rillo, Emilce Edith Schneeberger, Gustavo Citera

Full Text

DOI

Five-Year Outcomes of Systemic-Onset Juvenile Idiopathic Arthritis in India: Insights into Disease Course and Predictive Factors

Anand Prahalad Rao, Anugna B, Anil Kumar Tennelli, Debasis Patro, Paromita Nath, S. D. Subba Rao, Jyothi Raghuram

Full Text

DOI

Viral hepatitis screening guideline before biological drug use in rheumatic patients

Ömer Karadağ, Timuçin Kaşifoğlu, Birol Özer, Sabahattin Kaymakoğlu, Yeşim Kuş, Murat İnanç, Gökhan Keser, Sedat Kiraz

Full Text

DOI

Biologic treatments in Behçet’s disease

Fatma Alibaz-Öner, Haner Direskeneli

Full Text

DOI

Recent advances in Takayasu's arteritis

Fatma Alibaz-Öner, Sibel Zehra Aydın, Haner Direskeneli

Full Text

DOI

Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies

Mark C. Genovese, Patrick Durez, Roy Fleischmann, Yoshiya Tanaka, Daniel Furst, Hisashi Yamanaka, Igor Vasyutin, Tsutomu Takeuchi, Elena Korneva

Full Text

DOI

Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease

Ofer Levy, Arie Apel, Hossam Alhdor, Avraham Mizrachi, Nancy Agmon-Levin, Maya Koren-Michowitz, Mirit Amit-Vazina

Full Text

DOI

1 - 17 of 17 items